By contrast, this approach is not recommended following prior Grade ≥ 3 infusion reactions, in the presence of recurrent IRs despite optimized H1 premedication and strict rate control, or in cases where IgE-mediated anaphylaxis is strongly suspected; in these circumstances, desensitization or drug discontinuation should be prioritized in accordance with established guidelines. This evidence concerns the gene IGHE and anaphylaxis.